This webinar explores what is involved in the process of drug development on campus:
- The continuum from research to drug development
- Necessary discovery and development steps
- Clinical research - what regulators want
- IP protection and publishing
- Partnering to get your product to market
Meet your presenter: Dr. Elane Zelcer
Elane is a leader in the healthtech (biotech, medtech, digital health) sector. She has more than 25 years’ experience as an advisor to start-up and early stage companies, university & MRI spin-outs and research teams, with guidance for capital raising and commercialisation including risk management and governance. Her career spans director, scientific advisory board, executive management, management consulting, start-up founder and research roles, almost exclusively focused on healthtech. Elane is Deputy Chair of BioMelbourne Network, Director with AllergyPal, Director of her own company, BioConsult and a member of the scientific advisory board of AUSiMED (Australia Israel Medical Research). Her focus is the intersection between business and the research sector where she uses her knowledge and skills to assist start-up/early stage companies and research based organisations to develop novel, value-add healthtech products. Elane’s BSc (Hons), PhD & Grad Dip Mktg are from Monash University, and she completed post-doctoral studies at McMaster University, Hamilton, Ontario, Canada and the University of Virginia, Charlottesville, Virginia, USA. In 2017 she was awarded the Distinguished Alumni Award by Monash’s Faculty of Science, and is a Fellow of the Australian Institute of Company Directors.
PD+ streams: MedTech and Life Sciences | Commercialisation of Research
